Answers are grounded in this paper and cite their sources.
We discuss prospects for halloysite nanotubes, vaterite crystals and nanocellulose to enter the market of biomaterials for drug delivery and tissue engineering, and their potential for economically viable production from abundant natural sources.
No takes yet. Share an insight, caveat, or question.
Vikulina et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: